{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T13:34:17Z","timestamp":1785764057751,"version":"3.56.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"crossref","award":["IG23607\/2019"],"award-info":[{"award-number":["IG23607\/2019"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-03805-y","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T11:39:16Z","timestamp":1747222756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["BCR::ABL1 expression in chronic myeloid leukemia cells in low oxygen is regulated by glutamine via CD36-mediated fatty acid uptake"],"prefix":"10.1186","volume":"25","author":[{"given":"Caterina","family":"Mancini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Menegazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Peppicelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampaolo","family":"Versienti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Guasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pieraccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Rovida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Lulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Papucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Persio","family":"Dello Sbarba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Biagioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"3805_CR1","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s12964-023-01363-2","volume":"21","author":"C Busch","year":"2023","unstructured":"Busch C, Mulholland T, Zagnoni M, Dalby M, Berry C, Wheadon H. Overcoming BCR::ABL1 dependent and independent survival mechanisms in chronic myeloid leukaemia using a multi-kinase targeting approach. Cell Commun Signal. 2023;21:342.","journal-title":"Cell Commun Signal"},{"key":"3805_CR2","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1182\/blood-2016-10-745588","volume":"130","author":"G Cheloni","year":"2017","unstructured":"Cheloni G, Tanturli M, Tusa I, Ho DeSouza N, Shan Y, Gozzini A, et al. Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine. Blood. 2017;130:655\u201365.","journal-title":"Blood"},{"key":"3805_CR3","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1182\/blood-2016-09-696013","volume":"129","author":"TL Holyoake","year":"2017","unstructured":"Holyoake TL, Vetrie D. The chronic myeloid leukemia stem cell: stemming the tide of persistence. Blood. 2017;129:1595\u2013606.","journal-title":"Blood"},{"key":"3805_CR4","first-page":"1590","volume":"136","author":"GA Challen","year":"2020","unstructured":"Challen GA, Goodell MA. Clonal hematopoiesis: mechanisms driving dominance of stem cell clones. Blood. 2020;136:1590\u20138.","journal-title":"Blood"},{"key":"3805_CR5","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.exphem.2016.04.010","volume":"44","author":"J Chen","year":"2016","unstructured":"Chen J, Kang J-G, Keyvanfar K, Young NS, Hwang PM. Long-term adaptation to hypoxia preserves hematopoietic stem cell function. Exp Hematol. 2016;44:866\u2013e8734.","journal-title":"Exp Hematol"},{"key":"3805_CR6","doi-asserted-by":"publisher","first-page":"4979474","DOI":"10.1155\/2017\/4979474","volume":"2017","author":"G Cheloni","year":"2017","unstructured":"Cheloni G, Poteti M, Bono S, Masala E, Mazure NM, Rovida E, et al. The leukemic stem cell niche: adaptation to hypoxia versus oncogene addiction. Stem Cells Int. 2017;2017:4979474.","journal-title":"Stem Cells Int"},{"key":"3805_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3727\/096504022X16442289212164","volume":"29","author":"A Silvano","year":"2022","unstructured":"Silvano A, Menegazzi G, Peppicelli S, Mancini C, Biagioni A, Tubita A, et al. Lactate maintains BCR\/Abl expression and signaling in chronic myeloid leukemia cells under nutrient restriction. Oncol Res. 2022;29:33\u201346.","journal-title":"Oncol Res"},{"key":"3805_CR8","doi-asserted-by":"publisher","first-page":"84810","DOI":"10.18632\/oncotarget.13319","volume":"7","author":"S Bono","year":"2016","unstructured":"Bono S, Lulli M, D\u2019Agostino VG, Di Gesualdo F, Loffredo R, Cipolleschi MG, et al. Different BCR\/Abl protein suppression patterns as a converging trait of chronic myeloid leukemia cell adaptation to energy restriction. Oncotarget. 2016;7:84810\u201325.","journal-title":"Oncotarget"},{"key":"3805_CR9","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.4161\/15384101.2014.964107","volume":"13","author":"E Rovida","year":"2014","unstructured":"Rovida E, Peppicelli S, Bono S, Bianchini F, Tusa I, Cheloni G, et al. The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy. Cell Cycle. 2014;13:3169\u201375.","journal-title":"Cell Cycle"},{"key":"3805_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/metabo9050081","volume":"9","author":"J-P Mazat","year":"2019","unstructured":"Mazat J-P, Ransac S. The fate of glutamine in human metabolism. The interplay with glucose in proliferating cells. Metabolites. 2019;9:81.","journal-title":"Metabolites"},{"key":"3805_CR11","doi-asserted-by":"publisher","first-page":"4372","DOI":"10.3390\/cancers13174372","volume":"13","author":"M Poteti","year":"2021","unstructured":"Poteti M, Menegazzi G, Peppicelli S, Tusa I, Cheloni G, Silvano A, et al. Glutamine availability controls BCR\/Abl protein expression and functional phenotype of chronic myeloid leukemia cells endowed with stem\/progenitor cell potential. Cancers. 2021;13:4372.","journal-title":"Cancers"},{"key":"3805_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.neo.2019.10.004","volume":"22","author":"J Wappler","year":"2020","unstructured":"Wappler J, Arts M, R\u00f6th A, Heeren RMA, Peter Neumann U, Olde Damink SW, et al. Glutamine deprivation counteracts hypoxia-induced chemoresistance. Neoplasia. 2020;22:22\u201332.","journal-title":"Neoplasia"},{"key":"3805_CR13","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/s12276-020-00504-8","volume":"52","author":"HC Yoo","year":"2020","unstructured":"Yoo HC, Yu YC, Sung Y, Han JM. Glutamine reliance in cell metabolism. Exp Mol Med. 2020;52:1496\u2013516.","journal-title":"Exp Mol Med"},{"key":"3805_CR14","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.redox.2017.02.012","volume":"12","author":"DC Fuhrmann","year":"2017","unstructured":"Fuhrmann DC, Br\u00fcne B. Mitochondrial composition and function under the control of hypoxia. Redox Biol. 2017;12:208\u201315.","journal-title":"Redox Biol"},{"key":"3805_CR15","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3390\/cells8030214","volume":"8","author":"I Mylonis","year":"2019","unstructured":"Mylonis I, Simos G, Paraskeva E. Hypoxia-inducible factors and the regulation of lipid metabolism. Cells. 2019;8:214.","journal-title":"Cells"},{"key":"3805_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.amjms.2016.03.019","volume":"352","author":"JI Blum","year":"2016","unstructured":"Blum JI, Bijli KM, Murphy TC, Kleinhenz JM, Hart CM. Time-dependent PPAR\u03b3 modulation of HIF-1\u03b1 signaling in hypoxic pulmonary artery smooth muscle cells. Am J Med Sci. 2016;352:71\u20139.","journal-title":"Am J Med Sci"},{"key":"3805_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.celrep.2014.08.056","volume":"9","author":"K Bensaad","year":"2014","unstructured":"Bensaad K, Favaro E, Lewis CA, Peck B, Lord S, Collins JM, et al. Fatty acid uptake and lipid storage induced by HIF-1\u03b1 contribute to cell growth and survival after hypoxia-reoxygenation. Cell Rep. 2014;9:349\u201365.","journal-title":"Cell Rep"},{"key":"3805_CR18","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.jhep.2015.05.030","volume":"63","author":"B Hu","year":"2015","unstructured":"Hu B, Guo Y, Garbacz WG, Jiang M, Xu M, Huang H, et al. Fatty acid binding protein-4 (FABP4) is a hypoxia inducible gene that sensitizes mice to liver ischemia\/reperfusion injury. J Hepatol. 2015;63:855\u201362.","journal-title":"J Hepatol"},{"key":"3805_CR19","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1194\/jlr.D065664","volume":"57","author":"C Durandt","year":"2016","unstructured":"Durandt C, van Vollenstee FA, Dessels C, Kallmeyer K, de Villiers D, Murdoch C, et al. Novel flow cytometric approach for the detection of adipocyte subpopulations during adipogenesis. J Lipid Res. 2016;57:729\u201342.","journal-title":"J Lipid Res"},{"key":"3805_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/intbio\/zyaa006","volume":"12","author":"JH Hammel","year":"2020","unstructured":"Hammel JH, Bellas E. Endothelial cell crosstalk improves browning but hinders white adipocyte maturation in 3D engineered adipose tissue. Integr Biol (Camb). 2020;12:81\u20139.","journal-title":"Integr Biol (Camb)"},{"key":"3805_CR21","doi-asserted-by":"publisher","first-page":"216338","DOI":"10.1016\/j.canlet.2023.216338","volume":"571","author":"E Andreucci","year":"2023","unstructured":"Andreucci E, Biagioni A, Peri S, Versienti G, Cianchi F, Staderini F, et al. The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-fluorouracil, taxane-derived, and platinum-based drugs. Cancer Lett. 2023;571:216338.","journal-title":"Cancer Lett"},{"key":"3805_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/978-981-13-7342-8_6","volume":"1143","author":"P Dello Sbarba","year":"2019","unstructured":"Dello Sbarba P, Cheloni G. Tissue hypoxia and the maintenance of leukemia stem cells. Adv Exp Med Biol. 2019;1143:129\u201345.","journal-title":"Adv Exp Med Biol"},{"key":"3805_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.scr.2018.01.038","volume":"28","author":"S Bono","year":"2018","unstructured":"Bono S, Dello Sbarba P, Lulli M. Imatinib-mesylate enhances the maintenance of chronic myeloid leukemia stem cell potential in the absence of glucose. Stem Cell Res. 2018;28:33\u20138.","journal-title":"Stem Cell Res"},{"key":"3805_CR24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.chembiol.2016.03.007","volume":"23","author":"C-H Yao","year":"2016","unstructured":"Yao C-H, Fowle-Grider R, Mahieu NG, Liu G-Y, Chen Y-J, Wang R, et al. Exogenous fatty acids are the preferred source of membrane lipids in proliferating fibroblasts. Cell Chem Biol. 2016;23:483\u201393.","journal-title":"Cell Chem Biol"},{"key":"3805_CR25","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.4161\/cc.21944","volume":"11","author":"S Qie","year":"2012","unstructured":"Qie S, Liang D, Yin C, Gu W, Meng M, Wang C, et al. Glutamine depletion and glucose depletion trigger growth inhibition via distinctive gene expression reprogramming. Cell Cycle. 2012;11:3679\u201390.","journal-title":"Cell Cycle"},{"key":"3805_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.bbabio.2014.10.005","volume":"1847","author":"SA Mookerjee","year":"2015","unstructured":"Mookerjee SA, Goncalves RLS, Gerencser AA, Nicholls DG, Brand MD. The contributions of respiration and glycolysis to extracellular acid production. Biochim Et Biophys Acta (BBA) - Bioenergetics. 2015;1847:171\u201381.","journal-title":"Biochim Et Biophys Acta (BBA) - Bioenergetics"},{"key":"3805_CR27","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3324\/haematol.2017.169946","volume":"103","author":"N Landberg","year":"2018","unstructured":"Landberg N, von Palffy S, Askmyr M, Lilljebj\u00f6rn H, Sand\u00e9n C, Rissler M, et al. CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting. Haematologica. 2018;103:447\u201355.","journal-title":"Haematologica"},{"key":"3805_CR28","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.3389\/fonc.2020.01185","volume":"10","author":"J Drury","year":"2020","unstructured":"Drury J, Rychahou PG, He D, Jafari N, Wang C, Lee EY, et al. Inhibition of fatty acid synthase upregulates expression of CD36 to sustain proliferation of colorectal cancer cells. Front Oncol. 2020;10:1185.","journal-title":"Front Oncol"},{"key":"3805_CR29","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/ncb3625","volume":"19","author":"AL Boyd","year":"2017","unstructured":"Boyd AL, Reid JC, Salci KR, Aslostovar L, Benoit YD, Shapovalova Z, et al. Acute myeloid leukaemia disrupts endogenous myelo-erythropoiesis by compromising the adipocyte bone marrow niche. Nat Cell Biol. 2017;19:1336\u201347.","journal-title":"Nat Cell Biol"},{"key":"3805_CR30","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41580-020-0227-y","volume":"21","author":"P Lee","year":"2020","unstructured":"Lee P, Chandel NS, Simon MC. Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat Rev Mol Cell Biol. 2020;21:268\u201383.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3805_CR31","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.semcancer.2019.07.003","volume":"59","author":"AK Murugan","year":"2019","unstructured":"Murugan AK, mTOR. Role in cancer, metastasis and drug resistance. Sem Cancer Biol. 2019;59:92\u2013111.","journal-title":"Sem Cancer Biol"},{"key":"3805_CR32","doi-asserted-by":"crossref","unstructured":"Pike Winer LS, Wu M. Rapid analysis of glycolytic and oxidative substrate flux of cancer cells in a microplate. Sobol RW, editor. PLoS ONE. 2014;9:e109916.","DOI":"10.1371\/journal.pone.0109916"},{"key":"3805_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ceb.2015.02.002","volume":"33","author":"HF Hashemi","year":"2015","unstructured":"Hashemi HF, Goodman JM. The life cycle of lipid droplets. Curr Opin Cell Biol. 2015;33:119\u201324.","journal-title":"Curr Opin Cell Biol"},{"key":"3805_CR34","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3390\/cells8020172","volume":"8","author":"DC Fuhrmann","year":"2019","unstructured":"Fuhrmann DC, Olesch C, Kurrle N, Schn\u00fctgen F, Zukunft S, Fleming I, et al. Chronic hypoxia enhances \u03b2-oxidation-dependent electron transport via electron transferring flavoproteins. Cells. 2019;8:172.","journal-title":"Cells"},{"key":"3805_CR35","doi-asserted-by":"publisher","first-page":"6004","DOI":"10.3390\/cancers14236004","volume":"14","author":"L Lemberger","year":"2022","unstructured":"Lemberger L, Wagner R, Heller G, Pils D, Grunt TW. Pharmacological inhibition of lipid import and transport proteins in ovarian cancer. Cancers (Basel). 2022;14:6004.","journal-title":"Cancers (Basel)"},{"key":"3805_CR36","doi-asserted-by":"publisher","first-page":"1079076","DOI":"10.3389\/fcell.2022.1079076","volume":"10","author":"SL Guerrero-Rodr\u00edguez","year":"2022","unstructured":"Guerrero-Rodr\u00edguez SL, Mata-Cruz C, P\u00e9rez-Tapia SM, Velasco-Vel\u00e1zquez MA. Role of CD36 in cancer progression, stemness, and targeting. Front Cell Dev Biol. 2022;10:1079076.","journal-title":"Front Cell Dev Biol"},{"key":"3805_CR37","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0301-472X(99)00148-4","volume":"28","author":"J Rhodes","year":"2000","unstructured":"Rhodes J, York RD, Tara D, Tajinda K, Druker BJ. CrkL functions as a nuclear adaptor and transcriptional activator in Bcr-Abl-expressing cells. Exp Hematol. 2000;28:305\u201310.","journal-title":"Exp Hematol"},{"key":"3805_CR38","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.3390\/cancers12113443","volume":"12","author":"MGC Mostazo","year":"2020","unstructured":"Mostazo MGC, Kurrle N, Casado M, Fuhrmann D, Alshamleh I, H\u00e4upl B, et al. Metabolic plasticity is an essential requirement of acquired tyrosine kinase inhibitor resistance in chronic myeloid leukemia. Cancers (Basel). 2020;12:3443.","journal-title":"Cancers (Basel)"},{"key":"3805_CR39","doi-asserted-by":"publisher","first-page":"37747","DOI":"10.1074\/jbc.M105796200","volume":"276","author":"J Boren","year":"2001","unstructured":"Boren J, Cascante M, Marin S, Com\u00edn-Anduix B, Centelles JJ, Lim S, et al. Gleevec (STI571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells. J Biol Chem. 2001;276:37747\u201353.","journal-title":"J Biol Chem"},{"key":"3805_CR40","doi-asserted-by":"publisher","first-page":"6661","DOI":"10.1158\/1078-0432.CCR-04-0039","volume":"10","author":"S Gottschalk","year":"2004","unstructured":"Gottschalk S, Anderson N, Hainz C, Eckhardt SG, Serkova NJ. Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells. Clin Cancer Res. 2004;10:6661\u20138.","journal-title":"Clin Cancer Res"},{"key":"3805_CR41","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.leukres.2009.01.040","volume":"33","author":"M Breccia","year":"2009","unstructured":"Breccia M, Alimena G. The metabolic consequences of imatinib mesylate: changes on glucose, lypidic and bone metabolism. Leuk Res. 2009;33:871\u20135.","journal-title":"Leuk Res"},{"key":"3805_CR42","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s12672-022-00524-y","volume":"13","author":"LS Salaverry","year":"2022","unstructured":"Salaverry LS, Lombardo T, Cabral-Lorenzo MC, Gil-Folgar ML, Rey-Rold\u00e1n EB, Kornblihtt LI, et al. Metabolic plasticity in blast crisis-chronic myeloid leukaemia cells under hypoxia reduces the cytotoxic potency of drugs targeting mitochondria. Discov Onc. 2022;13:60.","journal-title":"Discov Onc"},{"key":"3805_CR43","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3390\/jcm8050707","volume":"8","author":"V Cuminetti","year":"2019","unstructured":"Cuminetti V, Arranz L. Bone marrow adipocytes: the enigmatic components of the hematopoietic stem cell niche. JCM. 2019;8:707.","journal-title":"JCM"},{"key":"3805_CR44","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.stem.2017.05.008","volume":"20","author":"G Grandl","year":"2017","unstructured":"Grandl G, Wolfrum C. Adipocytes at the core of bone function. Cell Stem Cell. 2017;20:739\u201340.","journal-title":"Cell Stem Cell"},{"key":"3805_CR45","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1182\/blood-2016-08-734798","volume":"129","author":"MS Shafat","year":"2017","unstructured":"Shafat MS, Oellerich T, Mohr S, Robinson SD, Edwards DR, Marlein CR, et al. Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment. Blood. 2017;129:1320\u201332.","journal-title":"Blood"},{"key":"3805_CR46","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","volume":"19","author":"H Ye","year":"2016","unstructured":"Ye H, Adane B, Khan N, Sullivan T, Minhajuddin M, Gasparetto M, et al. Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche. Cell Stem Cell. 2016;19:23\u201337.","journal-title":"Cell Stem Cell"},{"key":"3805_CR47","doi-asserted-by":"publisher","first-page":"e1146","DOI":"10.1002\/ctm2.1146","volume":"12","author":"MA Gonzalez","year":"2022","unstructured":"Gonzalez MA, Olivas IM, Bencomo-Alvarez AE, Rubio AJ, Barreto\u2010Vargas C, Lopez JL, et al. Loss of G0\/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism. Clin Translational Med. 2022;12:e1146.","journal-title":"Clin Translational Med"},{"key":"3805_CR48","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.3390\/cancers13143434","volume":"13","author":"K Naka","year":"2021","unstructured":"Naka K. Role of lysophospholipid metabolism in chronic myelogenous leukemia stem cells. Cancers. 2021;13:3434.","journal-title":"Cancers"},{"key":"3805_CR49","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1182\/blood-2014-12-617498","volume":"126","author":"MR Ricciardi","year":"2015","unstructured":"Ricciardi MR, Mirabilii S, Allegretti M, Licchetta R, Calarco A, Torrisi MR, et al. Targeting the leukemia cell metabolism by the CPT1a inhibition: functional preclinical effects in leukemias. Blood. 2015;126:1925\u20139.","journal-title":"Blood"},{"key":"3805_CR50","doi-asserted-by":"crossref","unstructured":"Minhajuddin M, Winters A, Ye H, Pei S, Stevens B, Gillen A et al. Lysosomal acid lipase A modulates leukemia stem cell response to venetoclax\/tyrosine kinase inhibitor combination therapy in blast phase chronic myeloid leukemia. haematol. 2024 [cited 2025 Mar 24]; Available from: https:\/\/haematologica.org\/article\/view\/haematol.2023.284716","DOI":"10.3324\/haematol.2023.284716"},{"key":"3805_CR51","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.canlet.2015.01.039","volume":"360","author":"H Shinohara","year":"2015","unstructured":"Shinohara H, Taniguchi K, Kumazaki M, Yamada N, Ito Y, Otsuki Y, et al. Anti-cancer fatty-acid derivative induces autophagic cell death through modulation of PKM isoform expression profile mediated by bcr-abl in chronic myeloid leukemia. Cancer Lett. 2015;360:28\u201338.","journal-title":"Cancer Lett"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03805-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-03805-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03805-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T12:12:59Z","timestamp":1747224779000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-025-03805-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3805"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-03805-y","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"2 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"176"}}